EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Small-Molecule Activators of PRMT1: Discovery, SAR Analyses, and Proapoptotic Effects in Pancreatic Cancer Cells

Sepideh Salehipour-Bavarsad, Christian Iking, Jonas Kammertöns, Caroline Bouchard, Marion Meixner, Michael Daude, Wieland Steinchen, Felix Terwesten, Johanna Senst, David Vonhören, Sinja Rakow, Anne Kagerhuber und 15 weitere

Journal of Medicinal Chemistry · 10.09.2026 · 69 (17) · 20116-20137

DOI: 10.1021/acs.jmedchem.5c03281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 20.08.2026. Verfasst von Sepideh Salehipour-Bavarsad und 26 weiteren Autor:innen. Beteiligte Einrichtung: Philipps-Universität Marburg , Institute for Molecular Biology and Tumor Research (IMT), BMFZ, Hans-Meerwein-Str. 2, Marburg35043, Germany. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Pancreatic Neoplasms, Apoptosis, Repressor Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jos?? Carreras Leuk??mie-Stiftung, German Research Council (DFG).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A substantial body of research implicates PRMTs in the pathogenesis of human diseases, primarily as oncoproteins or tumor suppressors in cancer. Starting from structure-based in silico screening of small-molecule databases, we predicted, synthesized, and assayed compounds aimed at specifically inhibiting selected PRMT family members. Unexpectedly, among several PRMT-inhibitory molecules we identified TR-07, a compound that selectively enhances the catalytic activity of PRMT1 in vitro. SAR analyses led to the design and synthesis of derivatives with increased potency in activating PRMT1 compared to TR-07 but at the cost of selectivity. TR-07 and its derivatives bind to the αY helix near the catalytic core of PRMT1. Treatment of pancreatic tumor cells with these PRMT1 activators enhanced global ADMA levels and augmented PRMT1’s apoptotic function in cell culture and mouse models. Our results establish TR-07 as the first selective, cell-active PRMT1 activator and underscore the therapeutic promise of this novel class of modulators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein-Arginine N-MethyltransferasesPancreatic NeoplasmsApoptosisRepressor ProteinsAntineoplastic AgentsSmall Molecule LibrariesEnzyme ActivatorsHumansStructure-Activity RelationshipAnimalsCell Line, TumorMiceDrug Discovery

Substanzen

Protein-Arginine N-MethyltransferasesPRMT1 protein, humanRepressor ProteinsAntineoplastic AgentsSmall Molecule LibrariesEnzyme Activators

Autor:innen und Institutionen

  • Philipps-Universität Marburg , Institute for Molecular Biology and Tumor Research (IMT), BMFZ, Hans-Meerwein-Str. 2, Marburg35043, Germany.
  • Philipps-Universität Marburg, Department of Medicinal Chemistry, Center for Tumor and Immune Biology (ZTI), Hans-Meerwein-Str. 3, Marburg35043, Germany.
  • Philipps-Universität Marburg, Institute of Pharmaceutical Chemistry, Marbacher Weg 8, Marburg35032, Germany.
  • Philipps-Universität Marburg, Center for Synthetic Microbiology (SYNMIKRO), Karl-von-Frisch-Str. 14, 35043Marburg, Germany.
  • Philipps-Universität Marburg , Department of Chemistry, Hans-Meerwein-Str. 4, Marburg35043, Germany.
  • Philipps-Universität Marburg, Imaging Core Facility, Center for Tumor Biology and Immune Biology, Hans-Meerwein-Str. 3, Marburg35043, Germany.

ORCID-Profile: Frank Abendroth, Olalla Vázquez, Detlef Klaus Bartsch, Peter Kolb, Wibke E Diederich, Uta-Maria Bauer

Förderung

  • Jos?? Carreras Leuk??mie-Stiftung
  • German Research Council (DFG)

Zitieren

APA

Salehipour-Bavarsad, S., Iking, C., Kammertöns, J., Bouchard, C., Meixner, M., Daude, M., Steinchen, W., Terwesten, F., Senst, J., Vonhören, D., Rakow, S., Kagerhuber, A., Martirosian, S., Roth, K., Hilger, D., Dörr, S., Bach, G., Trinh, V. T., Hauser, A., …, & Bauer, U. M. (2026). Small-Molecule Activators of PRMT1: Discovery, SAR Analyses, and Proapoptotic Effects in Pancreatic Cancer Cells. Journal of Medicinal Chemistry, 69(17), 20116-20137. https://doi.org/10.1021/acs.jmedchem.5c03281

Vancouver

Salehipour-Bavarsad S, Iking C, Kammertöns J, Bouchard C, Meixner M, Daude M, et al. Small-Molecule Activators of PRMT1: Discovery, SAR Analyses, and Proapoptotic Effects in Pancreatic Cancer Cells. Journal of Medicinal Chemistry. 2026;69(17):20116-20137. doi:10.1021/acs.jmedchem.5c03281

BibTeX
@article{SalehipourBavarsad2026,
  author = {Salehipour-Bavarsad, Sepideh and Iking, Christian and Kammertöns, Jonas and Bouchard, Caroline and Meixner, Marion and Daude, Michael and Steinchen, Wieland and Terwesten, Felix and Senst, Johanna and Vonhören, David and Rakow, Sinja and Kagerhuber, Anne and Martirosian, Sona and Roth, Katrin and Hilger, Daniel and Dörr, Stefanie and Bach, Gina and Trinh, Van Tuan and Hauser, Anett and Abendroth, Frank and Vázquez, Olalla and Bange, Gert and Bartsch, Jörg Walter and Bartsch, Detlef Klaus and Kolb, Peter and Diederich, Wibke E and Bauer, Uta-Maria},
  title = {Small-Molecule Activators of PRMT1: Discovery, SAR Analyses, and Proapoptotic Effects in Pancreatic Cancer Cells},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {17},
  pages = {20116--20137},
  doi = {10.1021/acs.jmedchem.5c03281}
}
Kostenlos starten →